Boston Scientific

Boston Scientific has a serious recall involving embolization tech

The FDA announced today that it has designated a Boston Scientific recall of its Obsidio conformable embolic as Class I, its most serious level of recall. The Obsidio embolic is a premixed embolic agent that is delivered in a minimally...

FDA approves AGENT DCB for coronary artery disease patients

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary...
- Advertisement -spot_img

Latest News

Weekly Chinese Horoscope from May 27- June 2, 2024: Check what’s in store for you

Rat (1948, 1960, 1972, 1984, 1996, 2008, 2020) This week's energy for those born in...
- Advertisement -spot_img